Golden State Wealth Management, LLC Biomarin Pharmaceutical Inc Transaction History
Golden State Wealth Management, LLC
- $667 Billion
- Q4 2024
A detailed history of Golden State Wealth Management, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Golden State Wealth Management, LLC holds 127 shares of BMRN stock, worth $8,112. This represents 0.0% of its overall portfolio holdings.
Number of Shares
127Holding current value
$8,112% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding BMRN
# of Institutions
645Shares Held
178MCall Options Held
2MPut Options Held
1.28M-
Black Rock Inc. New York, NY22.7MShares$1.45 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.3MShares$1.23 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.9MShares$1.21 Billion0.99% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$888 Million0.59% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.5MShares$670 Million0.16% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $11.9B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...